P1093: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF ZANUBRUTINIB (ZANU) VERSUS IBRUTINIB (IBRU) IN RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA (R/R MZL)

• Catherine Thieblemont,
• Kaijun Wang,
• Sam Keeping,
• Ina Zhang,
• Keri Yang,
• Boxiong Tang,
• Leyla Mohseninejad

Affiliations

Catherine Thieblemont

1 Hôpital Saint-Louis, Paris, France

Kaijun Wang

2 BeiGene USA, Inc., San Mateo, CA, USA and BeiGene Switzerland GmbH, Basel, Switzerland

Sam Keeping

3 PRECISIONheor, Vancouver, Canada

Ina Zhang

3 PRECISIONheor, Vancouver, Canada

Keri Yang

2 BeiGene USA, Inc., San Mateo, CA, USA and BeiGene Switzerland GmbH, Basel, Switzerland

Boxiong Tang

2 BeiGene USA, Inc., San Mateo, CA, USA and BeiGene Switzerland GmbH, Basel, Switzerland

Leyla Mohseninejad

2 BeiGene USA, Inc., San Mateo, CA, USA and BeiGene Switzerland GmbH, Basel, Switzerland